Immature myeloid cells and cancer-associated immune suppression

被引:260
作者
Kusmartsev, S [1 ]
Gabrilovich, DI [1 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA
关键词
cancer; immature myeloid cell; immune suppression; immune tolerance; T-cell response;
D O I
10.1007/s00262-002-0280-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Impaired balance between mature and immature myeloid cells is one of the hallmarks of cancer. In cancer patients as well as in mouse models there is increasing evidence that progressive tumor growth is associated with an accumulation of immature myeloid cells, monocytes/macrophages, and with a decreased number and function of dendritic cells (DC). This review examines recent findings on the contribution of immature myeloid cells (ImC) to cancer-induced immune suppression.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 59 条
[1]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]  
2-4
[3]  
Almand B, 2000, CLIN CANCER RES, V6, P1755
[4]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[5]   ACTIVATED MACROPHAGES INDUCE STRUCTURAL ABNORMALITIES OF THE T-CELL RECEPTOR-CD3 COMPLEX [J].
AOE, T ;
OKAMOTO, Y ;
SAITO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1881-1886
[6]   A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1+ macrophages that suppress naive CD4+ T cell proliferation via an IFN-γ and nitric oxide-dependent mechanism [J].
Atochina, O ;
Daly-Engel, T ;
Piskorska, D ;
McGuire, E ;
Harn, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4293-4302
[7]  
BELSKII Y, 1999, B EXP BIOL MED, V128, P677
[8]   Nonlinear scattering and analyticity properties of solitons [J].
Bronski, JC .
JOURNAL OF NONLINEAR SCIENCE, 1998, 8 (02) :161-182
[9]   Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells [J].
Bronte, V ;
Apolloni, E ;
Cabrelle, A ;
Ronca, R ;
Serafini, P ;
Zamboni, P ;
Restifo, NP ;
Zanovello, P .
BLOOD, 2000, 96 (12) :3838-3846
[10]  
Bronte V, 1999, J IMMUNOL, V162, P5728